XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robert K. who wrote (16432)	11/19/2003 12:24:59 PM
From: Bluegreen	of 17367

Bob, I posted that survey on Psoriasis in which it said over 80% surveyed had coverage that paid for meds. BTW who do you think pays for ALL THAT ENBREL for rheumatoid arthritis??? Sometimes I think people regard Raptiva as the only expensive medication out there. In fact it is one of MANY expensive medications out there........wasn't the first expensive medication and for sure won't be the last. Funny how these "expensive" medications are cheap when you take into account things like work productivity. I can't think of ONE corporation that would like "cheap" meds for their employees and then lose HUGE amounts of money through loss of productivity.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next